Venture Alternative Assets
Zentynel Frontier Investments
Specialized in biotechnology, the result of the collaboration between the Science & Life Foundation and Venturance Alternative Assets , focused on promoting the growth of emerging biotechnology companies.
Company Size
6 - 10 employees
Year Founded
2019
About Zentynel Frontier Investments
We are a joint venture of two leading players in science and business, complementing our capabilities to lead the fourth industrial revolution.
Investment fund manager specializing in alternative assets and consulting. Created in 2010, Venturance manages Private Equity, Venture Captial and other assets for more than US$ 250 million. It has experienced professionals from the financial, private equity and science and technology-based ventures sectors.
The Zentynel Fund is led by five General Partners. Each of them has extensive experience in the biotechnology sector, having developed and managed companies and/or investment funds in this industry.
Financials Beta
Business Model: Not Specified
Revenues: Not Specified
Expenses: Not Specified
Debt: Request
Operating Status: Active
Funding Raised: $0
Investment Rounds: 0 Rounds
Funding Stage: Not Specified
Last Funding Date: Not Specified
